JAK-话题@MedSci

#JAK#

115篇内容 | 2650人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1738068, encodeId=f9e61e3806816, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=NEJM：癌症风险高45%，心血管风险高36%？JAK、TNF抑制剂大PK, objectType=article, longId=295430, objectId=f3f92954303a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3f92954303a, replyNumber=0, likeNumber=75, createdTime=2022-03-08, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3f92954303a, moduleTitle=NEJM：癌症风险高45%，心血管风险高36%？JAK、TNF抑制剂大PK, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3f92954303a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738054, encodeId=58111e38054a4, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=治疗脱发！礼来JAK抑制剂 III 期研究成功, objectType=article, longId=208130, objectId=c159208130ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c159208130ad, replyNumber=0, likeNumber=70, createdTime=2021-09-15, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c159208130ad, moduleTitle=治疗脱发！礼来JAK抑制剂 III 期研究成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c159208130ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738060, encodeId=226c1e3806024, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Nat Commun : JAK2V617F 的克隆造血促进肺动脉高压，肺中性粒细胞中 ALK1 上调, objectType=article, longId=219430, objectId=d31021943025, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d31021943025, replyNumber=0, likeNumber=73, createdTime=2022-02-05, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d31021943025, moduleTitle=Nat Commun : JAK2V617F 的克隆造血促进肺动脉高压，肺中性粒细胞中 ALK1 上调, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d31021943025)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738057, encodeId=f7771e38057f5, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Nat Commun：JAK抑制剂托法替尼治疗系统性红斑狼疮, objectType=article, longId=212645, objectId=fd3221264551, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd3221264551, replyNumber=0, likeNumber=71, createdTime=2022-04-06, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd3221264551, moduleTitle=Nat Commun：JAK抑制剂托法替尼治疗系统性红斑狼疮, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd3221264551)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738053, encodeId=3c3b1e3805392, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Clin Cancer Res：JAK1抑制剂Itacitinib可有效预防CAR T细胞疗法引发的细胞因子释放综合征, objectType=article, longId=204517, objectId=6bae20451ef6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bae20451ef6, replyNumber=0, likeNumber=60, createdTime=2021-09-29, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bae20451ef6, moduleTitle=Clin Cancer Res：JAK1抑制剂Itacitinib可有效预防CAR T细胞疗法引发的细胞因子释放综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bae20451ef6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738052, encodeId=d8431e3805212, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Science Advances：JAK抑制剂Baricitinib将新冠COVID-19患者死亡率降低71%, objectType=article, longId=203491, objectId=bf832034914b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf832034914b, replyNumber=0, likeNumber=64, createdTime=2021-02-07, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf832034914b, moduleTitle=Science Advances：JAK抑制剂Baricitinib将新冠COVID-19患者死亡率降低71%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf832034914b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738055, encodeId=62c01e380553b, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=NEJM：口服JAK抑制剂abroctinib用于中重度特应性皮炎, objectType=article, longId=209011, objectId=43102090117d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43102090117d, replyNumber=0, likeNumber=84, createdTime=2022-03-04, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43102090117d, moduleTitle=NEJM：口服JAK抑制剂abroctinib用于中重度特应性皮炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43102090117d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738050, encodeId=72751e38050da, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=关节炎药物JAK抑制剂Baricitinib治疗斑秃：患者获得显著改善, objectType=article, longId=202774, objectId=0f2d202e740f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f2d202e740f, replyNumber=0, likeNumber=62, createdTime=2021-09-08, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f2d202e740f, moduleTitle=关节炎药物JAK抑制剂Baricitinib治疗斑秃：患者获得显著改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f2d202e740f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738046, encodeId=59661e380467f, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Blood：JAK/STAT抑制可增强CD8 T细胞对地塞米松诱导性细胞凋亡的敏感性, objectType=article, longId=199167, objectId=fa5b19916e5c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa5b19916e5c, replyNumber=0, likeNumber=64, createdTime=2021-05-28, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa5b19916e5c, moduleTitle=Blood：JAK/STAT抑制可增强CD8 T细胞对地塞米松诱导性细胞凋亡的敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa5b19916e5c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738035, encodeId=df8b1e38035f9, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=瑞德西韦联合JAK抑制剂治疗COVID-19：ACTT 2试验即将开展, objectType=article, longId=193896, objectId=d91f193896e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d91f193896e7, replyNumber=0, likeNumber=53, createdTime=2021-04-23, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d91f193896e7, moduleTitle=瑞德西韦联合JAK抑制剂治疗COVID-19：ACTT 2试验即将开展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d91f193896e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738049, encodeId=18971e38049f8, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Lancet Neurology：散发性Creutzfeldt-Jakob病新危险位点的鉴定和病因分析：全基因组关联研究, objectType=article, longId=202561, objectId=1add20256138, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1add20256138, replyNumber=0, likeNumber=61, createdTime=2021-08-30, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1add20256138, moduleTitle=Lancet Neurology：散发性Creutzfeldt-Jakob病新危险位点的鉴定和病因分析：全基因组关联研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1add20256138)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738048, encodeId=11691e380487a, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Rheumatology：接受JAK抑制剂的类风湿关节炎患者发生严重感染的风险, objectType=article, longId=201337, objectId=860520133e20, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=860520133e20, replyNumber=0, likeNumber=69, createdTime=2021-09-04, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=860520133e20, moduleTitle=Rheumatology：接受JAK抑制剂的类风湿关节炎患者发生严重感染的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=860520133e20)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738044, encodeId=45501e38044ca, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Blood：JAK-STAT通路调控骨髓瘤CD38表达，可作治疗靶点, objectType=article, longId=197677, objectId=a41b19e67770, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a41b19e67770, replyNumber=0, likeNumber=120, createdTime=2020-11-09, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a41b19e67770, moduleTitle=Blood：JAK-STAT通路调控骨髓瘤CD38表达，可作治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a41b19e67770)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738040, encodeId=5cd41e380408c, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=EULAR 2020：2期临床试验证明JAK1口服抑制剂Filgotinib在银屑病关节炎中的持久疗效, objectType=article, longId=195471, objectId=2fd71954e152, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fd71954e152, replyNumber=0, likeNumber=73, createdTime=2020-06-11, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fd71954e152, moduleTitle=EULAR 2020：2期临床试验证明JAK1口服抑制剂Filgotinib在银屑病关节炎中的持久疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fd71954e152)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738027, encodeId=a8401e38027b3, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Incyte的JAK1/JAK2抑制剂ruxolitinib乳膏治疗特应性皮炎的第二个III期临床成功, objectType=article, longId=188485, objectId=ddfc1884854b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddfc1884854b, replyNumber=0, likeNumber=64, createdTime=2021-01-05, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddfc1884854b, moduleTitle=Incyte的JAK1/JAK2抑制剂ruxolitinib乳膏治疗特应性皮炎的第二个III期临床成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddfc1884854b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738030, encodeId=764e1e380301d, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=JAK抑制剂ruxolitinib治疗重度COVID-19患者：正在进行评估, objectType=article, longId=191368, objectId=f47919136872, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f47919136872, replyNumber=0, likeNumber=80, createdTime=2020-05-27, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f47919136872, moduleTitle=JAK抑制剂ruxolitinib治疗重度COVID-19患者：正在进行评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f47919136872)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738051, encodeId=09391e3805146, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=EADV 2020：JAK抑制剂Baricitinib治疗湿疹，展现长期疗效和安全性, objectType=article, longId=202999, objectId=8918202999cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8918202999cd, replyNumber=0, likeNumber=71, createdTime=2021-10-08, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8918202999cd, moduleTitle=EADV 2020：JAK抑制剂Baricitinib治疗湿疹，展现长期疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8918202999cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738045, encodeId=ac5f1e380458f, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=JAK抑制剂Rinvoq治疗特应性皮炎：III期临床疗效显著, objectType=article, longId=197968, objectId=d9bf19e9686d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9bf19e9686d, replyNumber=0, likeNumber=75, createdTime=2021-05-11, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9bf19e9686d, moduleTitle=JAK抑制剂Rinvoq治疗特应性皮炎：III期临床疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9bf19e9686d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738024, encodeId=e6d51e380240c, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=JAK抑制剂baricitinib在III期特应性皮炎研究中显著改善皮肤炎症, objectType=article, longId=186909, objectId=12e1186909d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12e1186909d9, replyNumber=0, likeNumber=69, createdTime=2020-12-26, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12e1186909d9, moduleTitle=JAK抑制剂baricitinib在III期特应性皮炎研究中显著改善皮肤炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12e1186909d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738032, encodeId=aa7d1e380327d, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Incyte启动JAK抑制剂芦可替尼治疗COVID-19相关细胞因子风暴III期研究, objectType=article, longId=192565, objectId=2ba3192565fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ba3192565fa, replyNumber=0, likeNumber=73, createdTime=2021-02-17, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ba3192565fa, moduleTitle=Incyte启动JAK抑制剂芦可替尼治疗COVID-19相关细胞因子风暴III期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ba3192565fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

JAK

2020-05-29

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

NEJM：癌症风险高45%，心血管风险高36%？JAK、TNF抑制剂大PK

2022-03-08

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

治疗脱发！礼来JAK抑制剂 III 期研究成功

2021-09-15

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Nat Commun : JAK2V617F 的克隆造血促进肺动脉高压，肺中性粒细胞中 ALK1 上调

2022-02-05

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Nat Commun：JAK抑制剂托法替尼治疗系统性红斑狼疮

2022-04-06

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Clin Cancer Res：JAK1抑制剂Itacitinib可有效预防CAR T细胞疗法引发的细胞因子释放综合征

2021-09-29

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Science Advances：JAK抑制剂Baricitinib将新冠COVID-19患者死亡率降低71%

2021-02-07

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

NEJM：口服JAK抑制剂abroctinib用于中重度特应性皮炎

2022-03-04

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

关节炎药物JAK抑制剂Baricitinib治疗斑秃：患者获得显著改善

2021-09-08

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Blood：JAK/STAT抑制可增强CD8 T细胞对地塞米松诱导性细胞凋亡的敏感性

2021-05-28

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

瑞德西韦联合JAK抑制剂治疗COVID-19：ACTT 2试验即将开展

2021-04-23

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Lancet Neurology：散发性Creutzfeldt-Jakob病新危险位点的鉴定和病因分析：全基因组关联研究

2021-08-30

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Rheumatology：接受JAK抑制剂的类风湿关节炎患者发生严重感染的风险

2021-09-04

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Blood：JAK-STAT通路调控骨髓瘤CD38表达，可作治疗靶点

2020-11-09

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

EULAR 2020：2期临床试验证明JAK1口服抑制剂Filgotinib在银屑病关节炎中的持久疗效

2020-06-11

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Incyte的JAK1/JAK2抑制剂ruxolitinib乳膏治疗特应性皮炎的第二个III期临床成功

2021-01-05

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

JAK抑制剂ruxolitinib治疗重度COVID-19患者：正在进行评估

2020-05-27

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

EADV 2020：JAK抑制剂Baricitinib治疗湿疹，展现长期疗效和安全性

2021-10-08

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

JAK抑制剂Rinvoq治疗特应性皮炎：III期临床疗效显著

2021-05-11

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

JAK抑制剂baricitinib在III期特应性皮炎研究中显著改善皮肤炎症

2020-12-26

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Incyte启动JAK抑制剂芦可替尼治疗COVID-19相关细胞因子风暴III期研究

2021-02-17

科室
- - 订阅+
  - 更多科室
工具
服务